NCT06244355 Studies of Phenotypic and Functional Characteristics of Circulating Neutrophil Subpopulations in Patients With Lung Cancer Status RECRUITING Phase N/A
NCT06244264 The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis Status RECRUITING Phase NA
NCT06236516 One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors Status COMPLETED Phase NA
NCT06234735 Physical Activity Behavioral Change Intervention in Lung Cancer Status NOT_YET_RECRUITING Phase NA
NCT06232083 A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR) Status RECRUITING Phase PHASE1
NCT06229340 Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations Status RECRUITING Phase PHASE2
NCT06227897 Aumolertinib in EGFR-Mutant Resected Stage IB-IIIA NSCLC (AERESA). Status WITHDRAWN Phase PHASE2
NCT06225414 Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx) Status COMPLETED Phase NA
NCT06219174 Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO) Status SUSPENDED Phase PHASE1/PHASE2
NCT06217757 Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC Status RECRUITING Phase PHASE1/PHASE2
NCT06216782 Exploring the Frontiers of Neoadjuvant Therapy for Lung Cancer: a Prospective Observational Real-world Study Status RECRUITING Phase N/A
NCT06215326 Short-term Effects of Preoperative Exercise in Moderate-to-high Perioperative Risk Lung Cancer Patients Status RECRUITING Phase NA
NCT06202690 SP Robotic Versus VATS Anatomical Pulmonary Resection for Patients With NSCLC Status NOT_YET_RECRUITING Phase NA
NCT06202222 Interest of Intensive Postoperative Rehabilitation Following Minimally Invasive Lung Resection Status RECRUITING Phase NA
NCT06199895 Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer Status RECRUITING Phase PHASE2